Rite Aid Athletes Foot

Manufacturer
RITE AID
Effective date
2024-11-21
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:38:19

Label at a glance#

ProductRite Aid Athletes Foot
Active ingredientTOLNAFTATE
Label structure11 sections

Indications and uses

for effective treatment of most athlete's foot (tinea pedis), jock itch (tinea cruris) and ringworm (tinea corporis) for effective relief of itchy, scaly skin between the toes clears up most athlete's foot infection and with daily use helps keep it from coming back

Dosage and administration

clean the affected area and dry thoroughly apply a thin layer of the product over the affected area twice daily (morning and night) or as directed by a doctor supervise children in the use of this product For athlete's foot use daily for 4 weeks. If condition persists longer, consult a doctor pay special attention to the spaces between the toes wear well fitting ventilated shoes change shoes and socks at least onc...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Tolnaftate USP 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

  • for effective treatment of most athlete's foot (tinea pedis), jock itch (tinea cruris) and ringworm (tinea corporis)
  • for effective relief of itchy, scaly skin between the toes
  • clears up most athlete's foot infection and with daily use helps keep it from coming back

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

  • on children under 2 years of age unless directed by a doctor
OTC - WHEN USING SECTION

When using this product avoid contact with eyes

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • irritation occurs or if there is no improvement within 4 weeks (for athlete's foot and ringworm)
  • irritation occurs or if there is no improvement within 2 weeks (for jock itch)

Keep this and all drugs out of the reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

  • clean the affected area and dry thoroughly
  • apply a thin layer of the product over the affected area twice daily (morning and night) or as directed by a doctor
  • supervise children in the use of this product

For athlete's foot

  • use daily for 4 weeks. If condition persists longer, consult a doctor
  • pay special attention to the spaces between the toes
  • wear well fitting ventilated shoes
  • change shoes and socks at least once daily

For ringworm, use daily for 4 weeks. If condition persists longer, consult a doctor.

For jock itch, use daily for 2 weeks. If condition persists longer, consult a doctor.

This product is not effective on the scalp or nails.

Other information

SPL UNCLASSIFIED SECTION

  • Store at controlled room temperature 20°-25°C (68°-77°F)
  • close cap tightly after use

Inactive ingredients

INACTIVE INGREDIENT SECTION

Ceteth-20, Cetostearyl Alcohol, Chlorocresol, Mineral Oil, Propylene Glycol, Purified Water, Sodium Phosphate Monobasic, White Petrolatum

Questions?

OTC - QUESTIONS SECTION

<For questions or comments or ot reprot an undesired reaction or side effect, please call >

Principal Display Panel –  Tube

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

RITE AID Athleetes Foot  *Compare to Active Ingredient of Tinactin®

NDC 11822-0051-1

Antifungal

Cream (Tolnaftate 1%)

CURES and PREVENTS Most ATHLETE'S FOOT,

Relives Burning, Itching and cracking Net Wt. 1.0 OZ (28 g)

Principal Display Panel – TubePrincipal Display Panel – Tube

Principal Display Panel –  Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

RITE AID Athlete's Foot  NDC 11822-0051-1

Antifungal *Compare to Active Ingredient of Tinactin®

Cream (Tolnaftate 1%)

Cures and Prevents Most Athlete's Foot

relieves burning ,itching,& cracking

Net Wt. 1.0 OZ (28 g)

Principal Display Panel – CartonPrincipal Display Panel – Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
103951tolnaftate 1 % Topical CreamPSN2
103951tolnaftate 10 MG/ML Topical CreamSCD2
103951tolnaftate 1 % Topical CreamSY2

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
11822-0051-12026-01-29C16284748780-149896155-c466-586f-e063-e6dba90add90Rite Aid Athletes Foot
11822-0051-52026-01-29C16284748780-149896155-c466-586f-e063-e6dba90add90Rite Aid Athletes Foot

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11822-0051-1Rite Aid Athletes Foot1 in 1 CARTONCREAM12
11822-0051-1Rite Aid Athletes Foot28 g in 1 TUBECREAM282
11822-0051-5Rite Aid Athletes Foot14 g in 1 TUBECREAM142
11822-0051-5Rite Aid Athletes Foot1 in 1 CARTONCREAM12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11822-0051RITE AID ATHLETES FOOT (TOLNAFTATE) CREAM [RITE AID]2Legacy NDC, 4 package rows20241122_5148a438-a4ae-4d01-a020-211793ee2a94.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11822-005111822-0051-1, 11822-0051-5

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
664ee417-466e-4897-bd5d-1495f034d3ec5148a438-a4ae-4d01-a020-211793ee2a942024-11-21WarningsExact identifier
spl id: 664ee417-466e-4897-bd5d-1495f034d3ec
spl set id: 5148a438-a4ae-4d01-a020-211793ee2a94

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.